The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Oct. 04, 2016
Filed:
Mar. 05, 2014
Applicant:
Enteris Biopharma, Inc., Boonton, NJ (US);
Inventors:
Stephen M. Carl, Budd Lake, NJ (US);
John Stanley Vrettos, Union, NJ (US);
William Stern, Tenafly, NJ (US);
Assignee:
Enteris BioPharma, Inc., Boonton, NJ (US);
Primary Examiner:
Int. Cl.
CPC ...
A61K 31/65 (2006.01); A61K 31/351 (2006.01); A61K 31/7036 (2006.01); A61K 9/52 (2006.01); A61K 47/18 (2006.01); A61K 31/216 (2006.01); A61K 47/12 (2006.01); A61K 47/10 (2006.01); A61K 47/14 (2006.01); A61K 9/48 (2006.01); A61K 31/122 (2006.01); A61K 31/397 (2006.01); A61K 31/64 (2006.01); A61K 31/7012 (2006.01); A61K 9/00 (2006.01);
U.S. Cl.
CPC ...
A61K 47/186 (2013.01); A61K 9/0053 (2013.01); A61K 9/4858 (2013.01); A61K 9/4866 (2013.01); A61K 9/4891 (2013.01); A61K 31/122 (2013.01); A61K 31/216 (2013.01); A61K 31/351 (2013.01); A61K 31/397 (2013.01); A61K 31/64 (2013.01); A61K 31/65 (2013.01); A61K 31/7012 (2013.01); A61K 31/7036 (2013.01); A61K 47/10 (2013.01); A61K 47/12 (2013.01); A61K 47/14 (2013.01); A61K 47/183 (2013.01);
Abstract
The present invention provides solid oral dosage forms and methods of treating subjects in need thereof. The solid oral dosage forms of the present invention provide a mixture including at least one compound classified as BCS Class II, BCS Class III or BCS Class IV, where the compound does not include a peptide bond in the compound's molecular structure; an absorption enhancer; and coated organic acid particles; an enteric coating; and a water soluble barrier positioned between the mixture and the enteric coating.